Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
44.48
-0.28 (-0.63%)
Oct 15, 2025, 4:00 PM EDT
Roche Holding AG Revenue
Roche Holding AG had revenue of 31.85B CHF in the half year ending June 30, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 63.49B, up 4.80% year-over-year. In the year 2024, Roche Holding AG had annual revenue of 62.40B with 3.23% growth.
Revenue (ttm)
63.49B CHF
Revenue Growth
+4.80%
P/S Ratio
3.83
Revenue / Employee
614.90K CHF
Employees
103,249
Market Cap
305.41B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Nuo Therapeutics | 1.95M |
Roche Holding AG News
- 12 hours ago - Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? - Nasdaq
- 1 day ago - Wall Street Breakfast Podcast: Papa John's Delivers A Hot Slice - Seeking Alpha
- 2 days ago - Eli Lilly (LLY) and Roche's Blood Test for Alzheimer's Gets FDA Nod - GuruFocus
- 2 days ago - Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval - Seeking Alpha
- 2 days ago - Roche Holding's Blood-Based Alzheimer's Test Wins US FDA Approval - Nasdaq
- 2 days ago - Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Reuters
- 2 days ago - Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology - PRNewsWire
- 2 days ago - Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types - Business Wire